Company Name:Cara Therapeutics Inc.
CEO: Derek T. Chalmers

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Cara Therapeutics Inc is an emerging biotechnology company. It is focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.


Key numbers

Market Capitalization:807546700
Shares Outstanding: 46679000
Float: 42436019
Next Earning Date:2020-03-26
TTm EPS: -2.3932
TTm Dividend Rate:
200 days moving average:20.43
50 days moving average: 18.62
One day percent Change: 2.43



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,